Patent details

EP1963302 Title: POLYMORPHS OF A C-MET/HGFR INHIBITOR

Basic Information

Publication number:
EP1963302
PCT Application Number:
PCT/IB/2006/003383
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP068209881
PCT Publication Number:
WO/2007/066185
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
POLYMORPHS OF A C-MET/HGFR INHIBITOR
French Title of Invention:
POLYMORPHES D'UN INHIBITEUR DE C-MET/HGFR
German Title of Invention:
POLYMORPHE EINES C-MET/HGFR-INHIBITORS
SPC Number:

Dates

Filing date:
23/11/2006
Grant date:
27/02/2013
EP Publication Date:
27/02/2013
PCT Publication Date:
14/06/2007
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
03/09/2008
EP B1 Publication Date:
27/02/2013
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
23/11/2026
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/11/2006
 
 

Name:
Pfizer Products Inc.
Address:
Eastern Point Road, Groton, CT 06340, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
06/03/2013
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CUI Jingrong, Jean
Address:
United States (US)

2

Name:
TRAN-DUBE Michelle, Bich
Address:
United States (US)

Priority

Priority Number:
742676 P
Priority Date:
05/12/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C07D 401/04;

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
20
Annual Fee Amount:
300 Euro
Expected Payer:
Last Annual Fee Payment Date:
11/10/2024
Last Annual Fee Paid Number:
19
Last Annual Fee Paid Amount:
281 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages